| Dash Bio–Swift Ventures: investment, 202507 financing round totalling $11m incl co-investor Swift Ventures |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202410 seed financing round $6.5m led by Freestyle Capital |
2024-10-24 |
| Dash Bio–LifeX Ventures: investment, 202507 financing round totalling $11m incl co-investor LifeX Ventures |
2025-07-23 |
| Dash Bio–Freestyle Capital: investment, 202507 financing round totalling $11m incl co-investor Freestyle Capital |
2025-07-23 |
| Dash Bio–Drive Capital: investment, 202507 financing round totalling $11m incl co-investor Drive Capital |
2025-07-23 |
| Dash Bio–Cybernetix Ventures: investment, 202507 financing round totalling $11m incl co-investor Cybernetix Ventures |
2025-07-23 |
| Dash Bio–Aligned Fund: investment, 202507 financing round totalling $11m incl lead investor The Aligned Fund |
2025-07-23 |
| Danaher–Waters: LC systems, 202105– collab co-marketing Sciex offers MS systems interoperable with UPLC systems from Waters |
2021-05-11 |
| Danaher–UDG Healthcare: public relations, 202003 service existent for Cepheid by Canale Communciations |
2020-03-21 |
| Danaher–Sophia Genetics: genomic technologies, 202001– collab ww expansion IDT NGS enrichment products with Sophia Genetics DDM for clinical research |
2020-01-15 |
| Danaher–Sherlock Biosciences: molecular diagnostics, 202002– collab developm of Cepheid GeneXpert tests using CRISPR-based SHERLOCK technology |
2020-02-28 |
| Danaher–Seed Biosciences: cell dispenser, 202302– distribution excl of DinspenCell in US + Asia + resale in Europe by Molecular Devices |
2023-02-07 |
| Danaher–Scitara: laboratory software, 202102– license + collab product integration of Scitara DLX platform with IDBS Polar platform |
2021-02-02 |
| Danaher–mzio: mass spectrometry software, 202605 collab existent with Sciex on mzio industry-agnostic solutions |
2026-05-20 |
| Danaher–Ion Opticks: liquid chromatography, 202606– ww reseller + co-marketing agreem for Auroro Series SX colums + HeatSync w Sciex ZenoTOF systems |
2026-06-02 |
| Danaher–Ion Opticks: liquid chromatography, 202410– collab co-marketing of Aurora Series XS LC columns with ZenoTOF line MS systems of Sciex |
2024-10-25 |
| Danaher–Evosep: MS-based proteomics, 202111– collab developm proteomics workflows w joint customers using Evosep One + Sciex ZenoTOF 7600 system |
2021-11-01 |
| Danaher–CrestOptics: spinning disk microscopy, 202410– collab integration of Cicero spinning disk unit into Thunder Imager of Leica Microsystems |
2024-10-07 |
| Danaher–Celonis: management execution software, 202106 supply existent customer Danaher Corp |
2021-06-02 |
| Danaher–Advanced Solutions: laboratory automation equipment, 202301 collab developm BAB400 with ImageXpress for 3D Cell Culture + sales by MolDev |
2023-01-04 |
| CytoReason–Thermo Fisher: investment, 202407 financing round totalling $80m incl investor Thermo Fisher Scientific |
2024-07-17 |
| Cytespace Africa Laboratories–MLM Medical Labs: investment, 202506 acquisition of Cytespace by MLM |
2025-06-03 |
| Cubase Bio–Voima Ventures: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor Voima Ventures |
2026-02-17 |
| Cubase Bio–SEVERAL: investment, 202602 CubaseBio emerges with €3.9m in financing in private capital + convertibles(!) |
2026-02-17 |
| Cubase Bio–OTHER: investment, 202602 financing totalling €3.9m in private capital + convertibles incl several undisclosed private investors |
2026-02-17 |
| Cubase Bio–Nordic Science Investments: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor NSI |
2026-02-17 |
| Cubase Bio–Life Science Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Life Science Invest |
2026-02-17 |
| Cubase Bio–Illumina: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Illumina Ventures |
2026-02-17 |
| Cubase Bio–EU (govt): grant, 202602c grant €2m from EIC Transition Programme |
2026-02-17 |
| Cubase Bio–Almi Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Almi Invest |
2026-02-17 |
| CrystalsFirst–NexMR: fragment-based drug discovery, 202307– collab combining crystallography technology with NRM for drug discovery |
2023-07-24 |
| CrystalsFirst–Helmholtz: drug discovery technology, 202309–202410 collab developm in joint project LigandML with DESY with funding from IFB Hamburg |
2023-09-01 |
| Creoptix–Spectris: investment, 202201 acquisition of Creoptix AG by Malvern Panalytical |
2022-01-11 |
| Cold Spring Biotech–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Taiwan by Cold Spring Biotech |
2025-04-09 |
| Cold Spring Biotech–Nuclera: eProtein Discovery system, 202505– collab distribution by Cold Spring Biotech in Taiwan |
2025-05-06 |
| Cognate BioServices–SEVERAL: investment, 202001 financing round Series B led by EW Healthcare Partners + incl Medivate Partners |
2020-01-21 |
| Cognate BioServices–Medivate Partners: investment, 202001 financing round Series B incl co-investor Medivate Partners |
2020-01-21 |
| Cognate BioServices–Essex Woodlands: investment, 202001 financing round Series B incl existing + lead investor EW Healthcare Partners |
2020-01-21 |
| Cognate BioServices–Charles River: investment, 202102–202103 acquisition $875m in cash by Charles River |
2021-02-17 |
| CodeWrights–Endress+Hauser: investment, 202507 acquisition of remaining 33% in joint venture CodeWrights GmbH from Pepperl+Fuchs |
2025-07-01 |
| Cobra Biologics–Cognate BioServices: investment, 201911–202001 acquisition of Cobra by Cognate BioServices |
2019-11-04 |
| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Chemspeed–Bruker: investment, 202401– acquisition €na of Chemspeed Technology AG by Bruker |
2024-01-25 |
| Chemic Laboratories–Solvias: investment, 202106 acquisition €na by Solvias |
2021-06-17 |
| ChemAxon–Certara: investment, 202407–202410 acquisition of ChemAxon by Certara |
2024-07-09 |
| Chayon Laboratories–Nuclera: eProtein Discovery system, 202505– collab distribution by Chayon Laboratories Inc in South Korea |
2025-05-06 |
| Charles River–SAMDI Tech: drug discovery, 2018– collab using SAMDI MS technology for label-free high-throughput screening |
2018-01-01 |
| Champalimaud Foundation–Bruker: MRI system, 202605 supply existent 9.4 Tesla horizontal-bore MRI system at Preclinical MRI Laboratory |
2026-05-26 |
| Champalimaud Foundation–Bruker: MRI system, 202605 supply existent 16.4 Tesla (700 MHz) vertical-bore MRI/NMR system at Preclinical MRI Laboratory |
2026-05-26 |
| Champalimaud Foundation–Bruker: MRI system, 202605 supply BioSpec 18 Tesla preclinical MRI to Preclinical MRI Laboratory |
2026-05-26 |
| Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva |
2022-10-06 |
| Celonis–SEVERAL: investment, 202106 financing round Series D $1b co-led by Durable Capital Partners + T Rowe Price |
2021-06-02 |
| Cellesce–Danaher: investment, 202212 acquisition of Cellesce by Molecular Devices |
2022-12-06 |
| CatSci–Reach Separations: chromatography, 202311– collab strategic allliance offering method development for small molecule development services |
2023-11-28 |
| CatSci–Keensight Capital: investment, 202406 additional investment? by Keensight to support acquisition of Reach Separations by CatSci |
2024-06-25 |
| CatSci–Keensight Capital: investment, 202206 investment by Keensight Capital to support expansion |
2022-06-01 |
| Cansford Laboratories–Phenna Group: investment, 202304 acquisition by Phenna Group |
2023-04-18 |
| Canopy Biosciences–Bruker: investment, 202009 acquisition $24.4m of Canopy Biosciences LLC by Bruker Corp |
2020-09-11 |
| Cambridge Research & Instrumentation–Caliper: investment, 2010 acquisition of CRI by Caliper Life Sciences |
2010-01-01 |
| Bureau Veritas–SGS: investment, 202501– confirmed merger discussion |
2025-01-15 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| BugLab–Aber Instruments: investment, 202009–202102 acquisition €na of assets of BugLab LLC incl IP + trademarks |
2020-01-01 |
| Buck Institute–Nautilus Biotechnology: proteomics instrument, 202602 supply existent Buck Institute is early customer for new Voyager Platform |
2026-02-24 |
| Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab |
2020-08-07 |
| Bruker–TOFwerk: time-of-flight mass spectrometry, 2022205– collab strategic partnership for applied + industrial markets |
2022-05-10 |
| Bruker–Siscapa: MS-based proteomics, 2020505– collab strategic Biognosys beomces preferred service provider for Siscapa tech to biopharma customers |
2025-05-19 |
| Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery |
2024-08-07 |
| Bruker–Ion Opticks: liquid chromatography, 202412– supply costum chromatography column for MS-based proteomic services to Biognosys |
2024-12-05 |
| Bruker–Hitachi: thermocylcer, –202604 collab co-developm of My Genius PRO/Labospect GA-5 by EliTech + Hitachi High-Tech |
2026-04-17 |
| Bruker–Bico: MS-based single cell proteomics, 202111– co-marketing of Cellenion’s cellenONE with timsTOF SCP mass spectrometers |
2021-11-15 |
| Bruker–Atinary Technologies: AI-based lab software, 202608– strategic collab integrating SDLabs with Chemspeed robotics + Bruker FT-NMR |
2026-08-11 |
| Bruker–Alamar Biosciences: proteomics, 202404– strategic collab Biognosys using NULISA assays + joint research to explore plasma biology |
2024-04-04 |
| Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems |
2020-01-06 |
| Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery |
2020-07-23 |
| Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital |
2024-07-22 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma |
2023-02-15 |
| Biometra–Analytik Jena: investment, 200905 acquisition of Biometra by Analytik Jena |
2009-05-11 |
| BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED |
2021-07-26 |
| Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology |
2021-08-27 |
| Biognosys–Bruker: investment, 202301 acquisition $73.6m of majority share in Biognosys by Bruker |
2023-01-04 |
| Biogenity–Denmark (govt): investment, 202203 Innovation Fund Denmark invests in Innobooster project BioSWITCH |
2022-03-23 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Bioclinica–ERT: investment, 2021–2022 merger to become Clario |
2022-01-01 |
| Biocare Medical–Agilent: investment, 200603 acquisitiion $950m in cash by Agilent from investor group led by Excellere Parnters + GHO Capital Partners |
2026-03-09 |
| Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology |
2023-04-17 |
| Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED |
2022-10-31 |
| BigOmics–SEVERAL: investment, 202510 financing round 1st tranche $1.6m from Diffusion Capital Partners + business angels + TiVentures et al |
2025-10-08 |
| BigOmics–DNAnexus: cloud computing services, 202308– collab Omics Playground to become available on DNAnexus data platform |
2023-08-02 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH |
2024-11-21 |
| BIA Separations–Univ Zagreb: purification technology, 202002– commercial license + collab developm of virus + viral vector immunoaffinity purification |
2020-02-19 |
| BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED |
2020-10-02 |
| Becton Dickinson–Waters: investment, 202507–202602 merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Bang Trading–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in Thailand by Bang Trading |
2025-04-09 |
| B-MoGen Biotechnologies–Bio-Techne: investment, 201904 acquisition $17.4m of B-Mogen by Bio-Techne |
2019-06-04 |
| Axel Semrau–Trajan: investment, 202111 acquisition €19.85m by Trajan Group |
2021-11-18 |
| Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test |
2021-01-28 |
| Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD |
2021-01-28 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
1 2 3 4 5 6 
Deal: Collaboration or Financing
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
